Rappuoli R - Search Results

1

Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.

Buonsanti C, Balocchi C, Harfouche C, Corrente F, Galli Stampino L, Mancini F, Tontini M, Malyala P, Bufali S, Baudner B, De Gregorio E, Valiante NM, O'Hagan DT, Rappuoli R, D'Oro U. Buonsanti C, et al. Among authors: rappuoli r. Sci Rep. 2016 Jul 21;6:29063. doi: 10.1038/srep29063. Sci Rep. 2016. PMID: 27439378 Free PMC article.

2

The challenges of vaccinating the very young: lessons from a very old system of host defense.

Valiante NM, Rappuoli R, Insel RA, McInnes P, Hoeveler A. Valiante NM, et al. Among authors: rappuoli r. Vaccine. 1999 Jul 16;17(22):2757-62. doi: 10.1016/s0264-410x(99)00027-4. Vaccine. 1999. PMID: 10438043 No abstract available.

3

Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.

Ryan EJ, McNeela E, Murphy GA, Stewart H, O'hagan D, Pizza M, Rappuoli R, Mills KH. Ryan EJ, et al. Among authors: rappuoli r. Infect Immun. 1999 Dec;67(12):6270-80. doi: 10.1128/IAI.67.12.6270-6280.1999. Infect Immun. 1999. PMID: 10569737 Free PMC article.

4

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.

Baudner BC, Balland O, Giuliani MM, Von Hoegen P, Rappuoli R, Betbeder D, Del Giudice G. Baudner BC, et al. Among authors: rappuoli r. Infect Immun. 2002 Sep;70(9):4785-90. doi: 10.1128/IAI.70.9.4785-4790.2002. Infect Immun. 2002. PMID: 12183520 Free PMC article.

5

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.

Baudner BC, Giuliani MM, Verhoef JC, Rappuoli R, Junginger HE, Giudice GD. Baudner BC, et al. Among authors: rappuoli r. Vaccine. 2003 Sep 8;21(25-26):3837-44. doi: 10.1016/s0264-410x(03)00305-0. Vaccine. 2003. PMID: 12922117

6

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system.

Baudner BC, Morandi M, Giuliani MM, Verhoef JC, Junginger HE, Costantino P, Rappuoli R, Del Giudice G. Baudner BC, et al. Among authors: rappuoli r. J Infect Dis. 2004 Mar 1;189(5):828-32. doi: 10.1086/381708. Epub 2004 Feb 18. J Infect Dis. 2004. PMID: 14976599

7

N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines.

Baraldo K, Mori E, Bartoloni A, Petracca R, Giannozzi A, Norelli F, Rappuoli R, Grandi G, Del Giudice G. Baraldo K, et al. Among authors: rappuoli r. Infect Immun. 2004 Aug;72(8):4884-7. doi: 10.1128/IAI.72.8.4884-4887.2004. Infect Immun. 2004. PMID: 15271954 Free PMC article.

8

The safety of vaccines.

O'Hagan DT, Rappuoli R. O'Hagan DT, et al. Among authors: rappuoli r. Drug Discov Today. 2004 Oct 1;9(19):846-54. doi: 10.1016/S1359-6446(04)03234-9. Drug Discov Today. 2004. PMID: 15381137 Free PMC article. Review.

9

Inside sensors detecting outside pathogens.

De Gregorio E, Rappuoli R. De Gregorio E, et al. Among authors: rappuoli r. Nat Immunol. 2004 Nov;5(11):1099-100. doi: 10.1038/ni1104-1099. Nat Immunol. 2004. PMID: 15496945 No abstract available.

10

Novel approaches to vaccine delivery.

O'Hagan DT, Rappuoli R. O'Hagan DT, et al. Among authors: rappuoli r. Pharm Res. 2004 Sep;21(9):1519-30. doi: 10.1023/b:pham.0000041443.17935.33. Pharm Res. 2004. PMID: 15497674 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

820 results

Search Page

Filters